Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in Southern Europe: Evidence for the HTLV-IIa and HTLV-IIb subtypes

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 4, 1996, Pages 384-391

  Vallejo, Alejandro ^a,b   Ferrante, Pasquale ^c   Soriano, Vincent ^b   Calabrò, Maria Luisa ^d   Mancuso, Roberta ^e   Heredia, Alonso ^a   Mannella, Emilio ^f   Favero, Anna ^d   Garcia Sáiz, Alfredo ^b   Chieco Bianchi, Luigi ^d   González Lahoz, Juan ^b   Hewlett, Indira K ^a,g  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^f Italian Red Cross   (Italy)

^g Div of Molec Virol and Immunology   (United States)

Author keywords

Blood donors; HTLV II; Injecting drug users; Italy; Restriction fragment length polymorphism; Sequencing; Spain; Subtyping

Indexed keywords

ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; INTRAVENOUS DRUG ABUSE; ITALY; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROVIRUS; SOUTHERN EUROPE; SPAIN;

HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 2; UNIDENTIFIED RETROVIRUS;

EID: 10544231871     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199612010-00013     Document Type: Article

References (42)

1. Hjelle B, Appenzeller O, Mills R, Alexander S, TorrezMartinez N, Jahnke R, Ross G. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339:645-6.
2. Harrington W Jr, Sheremata W, Hjelle B, et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411.
3. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993;33:392-6.
4. Hall WW, Takahashi H, Liu C, et al. Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol 1992;66:2456-63.
5. Dube DK, Sherman MO, Saksena N, et al. Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993;67:1175-84.
6. Ishak R, Harrington WJ, Azevedo VN, et al. Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-21.
7. Salemi M, Cattaneo E, Casoli C, Bertazzoni U. Identification of IIa and lib molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:516-20.
8. Flö RW, Samdal HH, Kalland KH, the Oslo HIV Cohort Study Group, Nilsen A, Haukenes G. Diagnosis of infection with human T-lymphotropic virus type II (HTLV-II) in Norwegian HI V-infected individuals. Clin Diagn 1993;1:143-52.
9. Neel JV, Biggar RJ, Sukernik RI. Virologic and genetic studies relate Amerind origins to the indigenous people of the Mongolia/Manchuria/Southeastern Siberia region. Proc Natl Acad Sci USA 1994;91:10,737-41.
10. Mauclère P, Mahieux R, Garcia-Calleja JM, et al. A new HTLV type II subtype a isolate in an HIV type 1-infected prostitute from Cameroon, Central Africa. HIV Res Hum Retroviruses 1995;11:989-93.
11. Igarashi T, Yamashita M, Miura T, et al. Isolation and genomic analysis of human T lymphotropic virus type II from Ghana. AIDS Res Hum Retroviruses 1993;9:1039-42.
12. Hjelle B, Zhu SW, Takahashi H, Ijichi S, Hall WW. Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus. J Infect Dis 1993;168:737-40.
13. Lairmore MD, Jacobson S, Garcia F, et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990;87:8840-4.
14. Levine PH, Jacobson S, Elliott R, et al. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9: 123-7.
15. Biglione M, Gessain A, Quiruelas S, et al. Endemic HTLV-II infection among Tobas and Matacos Amerindians from North Argentina. J Acquir Immune Defic Syndr 1993;6: 631-3.
16. Ferrer JF, Del Pino N, Esteban E, et al. High rate of infection with the human T-cell leukemia retrovirus type II in four indian populations of Argentina. Virology 1993;197:576-84.
17. Ijichi S, Zaninovic V, Leon S, et al. Identification of human T cell leukemia virus type IIb infection in the Wayu, an aboriginal population of Columbia. Jpn J Cancer Res 1993; 84:1215-8.
18. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw GM, Blattner WA. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992;166:100-7.
19. Pardi D, Hjelle B, Folks TM, Lal RB. Genotypic characteristics of the HTLV-II isolates from Amerindian and non-Indian populations. Virus Genes 1995;10:27-35.
20. Soriano V, Calderon E, Esparza B, et al. HTLV-I/II infections in Spain. Int J Epidemiol 1993;22:716-9.
21. Vallejo A, Garcia-Saiz A. Isolation and nucleotide sequence analysis of human T-cell lymphotropic virus type II in Spain. J Acquir Immune Defic Syndr 1994;7:517-9.
22. Zella DL, Mori L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet 1990;2:575-6.
23. Calabrò ML, Luparello M, Grottola A, et al. Detection of human T lymphotropic virus type II/b human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J Infect Dis 1993;168:1273-7.
24. Lee H, Idler KB, Swanson P, et al. Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian IV drug users. Virology 1993;196: 57-69.
25. Gessain A, Tuppin P, Kazanji M, Cosnefroy JY, Georges-Courbot MC, Georges AJ, de Thé G. A distinct molecular variant of HTLV-IIb in Gabon, Central Africa. AIDS Res Hum Retroviruses 1994;10:753-4.
26. Gessain A, Mauclere P, Froment A, et al. Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype b, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc Natl Acad Sci USA 1995;92: 4041-5.
27. Bolton WV, Kenrick KG, Dwyer DE, Cunningham AL, Wylie BR, Saksena NK. Partial nucleotide sequence analysis of the first case of human T lymphotropic virus type II from Australia. AIDS Res Hum Retroviruses 1995;11:765-7.
28. Switzer WM, Pieniazek D, Swanson P, et al. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995;69: 621-32.
29. Eiraku N, Monken C, Kubo T, et al. Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res Hum Retroviruses 1995;11:625-36.
30. Switzer WM, Owen SM, Pieniazek DA, Nerurkar VR, Duenas-Barajas E, Heneine W, Lal RB. Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb. Virus Genes 1995;10:153-62.
31. Colombo E, Magistrelli C, Mendozzi E, Cattaneo E, Achilli G, Ferrante P. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods. J Med Virol 1995;47:10-5.
32. Higgins DG, Bleasby AJ, Fuchs R. CLUSTAL V: improved software for multiple sequence alignement. Comput Appl Biol Sci 1992;8:189-91.
33. Josef Felsenstein, University of Washington. Web page: http://evolution.genetics.washington.edu/phylip.html.
34. Shimotohno K, Takahashi Y, Shimizu N, et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci USA 1985;82:3101-5.
35. Pardi D, Switzer WM, Hadlock KG, Kaplan JE, Lal RB, Folks TM. Complete nucleotide sequence of an American human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from Guaymi Indian. J Virol 1993;67:4659-64.
36. Goubau P, Liu HF, de Large GG, Vandamme AM, Desmyter J. HTLV-II seroprevalance in Pygmies across Africa since 1970. AIDS Res Hum Retroviruses 1993;9:709-13.
37. Froment A, Delaporte E, Dazza MC, Larouze B. HTLV-II among Pygmies from Cameroon. AIDS Res Hum Retroviruses 1993;9:707.
38. Gessain A, Fretz C, Koulibaly M, et al. Evidence of HTLV-II infection in Guinea, West Africa. J Acquir Immune Defic Syndr 1993;6:324-5.
39. Vallejo A, Benito A, Varela JM, Casado C, Roche J, Alvar J, Garcia-Saiz A. Human T-cell leukaemia virus-I/II infection in Equatorial Guinea. AIDS 1994;8:1501-3.
40. Vallejo A, Soriano V, Gutierrez M, Gomez C, Gonzalez-Lahoz J. HTLV-I and HTLV-II in Africans. Genitourin Med 1995;71:53.
41. Goubau P, Desmyter J, Swanson P, et al. Detection of HTLV-I and HTLV-II infection in Africans Using type-specific envelope peptides. J Med Virol 1993;39:28-32.
42. Ureta Vidai A, Gessain A, Yoshida M, et al. Phylogenetic classification of human leukemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes. J Gen Virol 1994;75:3655-66.